PTC Therapeutics will also get the FDA's priority review voucher, which allows a drug developer to expedite the review ...

Potential Tropical Cyclone Nineteen (PTC 19) has formed in the western Caribbean. This system will likely to develop into the ...

PTC will release its quarterly results on Nov. 6, with analysts forecasting year-over-year growth in earnings and revenue ...

The disturbance in the Caribbean formerly known as Invest 99L has now been designated as Potential Tropical Cyclone 19. PTC ...

PTC Forecasts Quarterly Revenue Below Estimates on Tight Tech Spending (Reuters) - Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued ...

Analysts expect PTC to report an earnings per share (EPS) of $1.45. PTC bulls will hope to hear the company announce they've ...

Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $43 from $31 and keeps an Equal Weight rating on the shares. The ...

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...

BOSTON, Nov. 6, 2024 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that its Board of Directors has authorized the repurchase of up to $2 billion worth of PTC common stock through September 30 ...

Berenberg downgraded PTC (PTC) to Hold from Buy with a price target of $196, down from $210. The firm says it is not seeing any signs of stabilization in the macro headwinds in PTC’s core end ...

Real-time index price for S&P 500 Index (INX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

As an array of developers push their Friedreich’s ataxia (FA) drugs along, PTC Therapeutics Inc.’s recent update on its program piqued thirst for the 15-lipoxygenase inhibitor vatiquinone. Warren, N.J ...